Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.66 USD
Change Today -0.17 / -2.17%
Volume 994.6K
PGNX On Other Exchanges
As of 3:57 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark R. Baker J.D.

Chief Executive Officer, Director and Member of Science & Strategy Committee,Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 3 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Mark R. Baker, J.D. has been the Chief Executive Officer of Progenics Pharmaceuticals, Inc. since March 2011 and served as its President from September 2009 to March 3, 2011. Mr. Baker served as a Secretary and General Counsel of Progenics Pharmaceuticals, Inc. since June 20, 2005 and served as its Executive Vice President-Corporate from 2008 to 2009. He served as Senior Vice President of Progenics Pharmaceuticals Inc., since June 20, 2005. He served as Chief Legal ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

Chairman of the Board, Member of Executive Committee and Member of Compensation Committee
Non-Executive Chairman of the Board, Chief Legal Officer of Contigroup and Senior Vice President of Contigroup
Chief Executive Officer, Director and Member of Science & Strategy Committee


School Of Law, Columbia University
Columbia Business School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$555,699

Stock Options*

All Other Compensation$16,588
Exercisable Options823,819
Exercisable Options Value$726,450
Unexercisable Options284,222
Unexercisable Options Value$579,920
Total Value of Options$1,306,370
Total Number of Options1,108,041

Total Compensation*

Total Annual Cash Compensation$850,137
Total Short Term Compensation$555,699
Other Long Term Compensation$16,588
Total Calculated Compensation$1,320,149
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $7.66 USD -0.17


Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Arena Pharmaceuticals, Inc.
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at